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ABSTRACT 
The aim of the present study was to detect and analyze adverse drug reactions of antibiotics in a tertiary care hospital. This was a 
prospective observational study carried out in the Department of General Medicine (Osmania General Hospital) over a period of six 
months. The present study was conducted to assess the prescription pattern of antibiotic usage. Standard pro-forma was used to 
collect the information regarding antibiotics, its dose, duration, first line of antibiotics and second line of antibiotics and adverse 
drug reactions. A Total of 100 ADRs was reported from 100 patients during the study period with female predominance (72%) over 
males. The average age of the patients in the study was found to be 55-70 years. The majority of the ADRs occurred in the age group 
of 40-80 years. More number of ADRs was from General Medicine Departments in which the most affected organ systems were the 
GIT (22%) and the skin (19%). The antibiotic classes mostly accounted were cephalosporin (16%) followed by other. The severity 
assessment revealed that most of them were moderate followed by mild and severe reactions. Of the reported reactions, 30 % were 
definitely preventable and causality assessment was done which showed that the reactions were probable, possible. Results show that 
cephalosporin was extensively used in the department of General medicine. The system should promote the spontaneous reporting of 
adverse drug reactions to antibiotics. Proper documentation and periodic reporting to regional Pharmacovigilance centre’s to ensure 
drug. 
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INTRODUCTION 
Drugs are the most common medical interventions, 
primarily used to relieve sufferings. But it has been 
recognized long ago that drug themselves can prove 
fatal; as the saying rightly goes ‘‘Drugs are Double 
Edged Weapons’’. Adverse reaction monitoring and 
reporting are very important in identifying the adverse 
reaction trends in local population.
1 
The WHO defines 
an ADR as ‘‘any response to a drug which is noxious 
and unintended, and which occurs at doses normally 
used in man for prophylaxis, diagnosis or therapy of 
disease, or for the modification of physiologic 
function.’’ Thus this definition excludes overdose 
(either accidental or intentional), drug abuse, and 
treatment failure and drug administration errors.
2 
Adverse Drug Reactions (ADRS) are important causes 
of mortality and morbidity in both hospitalized and 
ambulatory patients. In many countries ADRs rank 
among the top 10leading causes of mortality. So there is 
a need to study ADRs seriously to create awareness 
about ADRs among patients to motivate health care 
professionals in the hospital to report ADRs to minimize 
the risk. Early detection, evaluation and monitoring of 
ADR are essential to reduce harm to patients and thus 
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improve public health.
3 
The safety of drug prescribing 
has become a highly visible topic in medicine. Patients 
constitute a vulnerable group with regard to rational 
drug prescribing since many new drugs are released into 
the market without the benefit of even limited 
experience. This deficiency causes a practitioner to often 
prescribe drugs in an ‘off label’ manner, thereby 
increasing the risk of drug toxicity. As more drugs are 
marketed and as more individuals take multiple drugs, 
the occurrence of Adverse Drug Reaction will probably 
continue to increase. Therefore, better approaches must 
be devised for reporting and assessment and 
management to find individuals who present with drug 
induced diseases. 
3
 
ADRs have a considerable negative impact on both 
health and healthcare costs. ADR monitoring and 
reporting activity is in its infancy in India. India is a 
developing country with a large drug consuming 
population. It is the fourth largest producer of 
pharmaceuticals in the world with more than 6000 
licensed drug manufacturers and over 60,000 branded 
formulations. Thus it is essential that the drug treatment 
should be safe, efficacious and cost effective. It is also 
emerging as a clinical trial hub exposing larger 
population to newer drug treatments. 
 The Ministry of Health and Family Welfare had 
initiated the National Pharmacovigilance Program 
(NPP) on 1st January 2005 which was further revived in 
July 2010. This program is overseen by the Central 
Drugs Standard Control Organization (CDSCO), New 
Delhi .4 Antibiotics belong to different classes such as 
penicillin’s, cephalosporins, sulfonamides, and amino 
glycosides, and they vary in respect of their mechanism 
of actions and adverse effects. Antibiotics are used 
commonly in routine practice for treatment and 
prophylaxis of various disease conditions4 .Over half of 
all hospitalized patients are treated with antimicrobial 
agents and their use account for 20–50% of drug 
expenditures in hospitals. The total costs associated with 
antibiotics are not only related to antibiotic use itself, 
but also to co-medication and adverse drug events. The 
main aim of this study was to detect and analyze 
Adverse Drug Reactions (ADR) to antimicrobial drugs 
in hospitalized patients of a tertiary care hospital. 
METHODOLOGY 
A prospective observational study on adverse drug 
reaction is carried out in Department of General 
Medicine of Osmania General Hospital Hyderabad, 
India a tertiary care hospital for a period of 6 months on 
100 cases. The present study was approved by 
Institutional Ethics Committee (MCP/PD/PR/10). The 
present study was conducted to assess the prescription 
pattern of antibiotic usage. Standard pro-forma was used 
to collect the information regarding antibiotics, its dose, 
duration, first line of antibiotics and second line of 
antibiotics and adverse drug reactions. Patient of all age 
groups of either gender more than 18 years who 
developed adverse drug reactions of antibiotics in 
hospital or admitted due to ADRs were included for the 
study. Patients with intentional and accidental 
poisoning, patient doesn’t want to give consent and 
patients suffering from severe hepatic, renal and cardiac 
impairment were excluded from the study. The data for 
the study were taken from Case sheets, investigation 
reports of patients who had experienced an ADR, 
personal interviews with reporting persons or clinicians, 
patient’s attendant, past history of medication use. The 
socio demographic clinical characteristics and 
medication prescribed was documented in special design 
form. Analysis was carried out to assess the prevalence, 
severity and significance identified using Microsoft 
excels. 
RESULTS  
During the study period, a total of 100 antibiotic 
Adverse Drug Reactions were reported among 100 
patients admitted for antibiotic use. The incidence rate 
of antibiotic Adverse Drug Reactions was found to be 
100%. Six month study revealed that Figure 1 shows 
female patients 72 (72%) predominated over males 28 
(28%) in ADR occurrence. Figure 2 shows the age wise 
distribution of the total population and revealed that the 
average age of the patients in the study was found to be 
55-80 years. The majority of the ADRs occurred in the 
age group of 51-60 years. The antibiotic classes affected 
with ADRs are shown in (Table 1) which revealed that 
cephalosporin’s were the most accounted antibiotic class 
16 (34.69%) followed by fluoro-quinolones 13, 
aminoglycosides 13, penicillins 11, miscellaneous 
antibiotics 7, Sulphonamide 7, Tetracycline 5, Azoles 4. 
Of the reported ADRs, Type A 13 (16.25%) was the 
most common compared to Type B 45(56.25%) 
reactions according to the ADR classification by Rawlin 
and Thomson (Figure 3). In 20% cases the suspected 
drug was withdrawn while no change was made with the 
suspected drug in 1% and the dose was altered in (5%) 
cases. From this study, it was found out that there was a 
recovery from ADRs in total of 100 patients 100 % 
although 20% had fatal ADRs. 
Figure 4 shows the probability assessment of reported 
ADRs as per the Naranjo scale and revealed that 1 (1%) 
were High probable, 89 (89%) were possible, 6 (6%) 
were doubt full 4 (4%). Figure 5 shows the distribution 
of patients outcomes of ADRs in which life threatening 
15, hospitalized 22 and discharged 63 patients. Figure 6 
shows the distribution of ADRs based on common, 
uncommon, rare and very rare. 
 
 
Figure 1: Distribution of Subjects Based Upon the 
Gender. 
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Figure 2: ADR based on age distribution of patients. 
 
Figure 3: Classifications of ADRS based on Rawlin and 
Thomson 
 
Figure 4: Probability assessment (using the Naranjo 
scale) 
 
Figure 5: Distribution of patients based on outcomes of 
ADR 
 
 
Figure 6: Classification of ADR common, uncommon, 
rare, very rare
 
Table 1: Adverse drug reactions observed during the studyClass of Antibiotics and shows Therapeutic class of 
antibiotics implicated to cause ADR (n=100) 
S. 
No. 
Class of Drug Name of Drug  Adverse drug reaction 
No. of ADRs 
(100) 
% of 
ADR 
1 Sulphonamide 
Sulfadoxine Serious allergic skin reaction 1 1% 
Mafenide Metabolic acidosis 2 2% 
Sulfasalazine Headache 2 2% 
Sulfadiazine Allergic skin reactions 1 1% 
Sulfimoxole Crystalluria 1 1% 
   2 
Sulphonamides and 
cotrimaxazole 
Cotrimoxazole Megaloblasticanemia 1 1% 
Trimethoprim Ulcers on tongue 1 1% 
  3 Penicillin’s 
Penicillamine Good pastures syndrome 1 1% 
Penicillin g 
JarischHerxheimer reaction, 
Hyperkalaemia 
4 4% 
Ampicillin Black hairy tongue 4 4% 
Ticarcillin Bleeding 1 1% 
Carbenicillin Bleeding 1 1% 
   4 Cephalosporins 
Ciprofloxacin 
Swelling of lips, Severe headache, 
Pulmonary edema 
3 3% 
Cefaclor Drug fever skin rashes 2 2% 
Cefotaxime Asthma 1 1% 
Cefixime Diarrhoea 1 1% 
Ceftriaxone Angioedema 1 1% 
Cephalexin Hallucinations 3 3% 
Cefazolin Hallucinations 2 2% 
Cefpodoxime Asthma 1 1% 
Cefipime Disulfuram like reaction 1 1% 
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Cefadroxil General moniliaris 1 1% 
   5 Beta lactam inhibitors 
Amoxcillin and 
clavunic acid 
Moderate rise in( ALT) 1 1% 
   6 Tetracycline 
Demeclocycline Diabetes insipidus 1 1% 
Minocycline Ataxia vertigo nystagmus 1 1% 
Tetracycline 
Skin rashes, Maculopupular and 
Erythromatous rashes 
2 2% 
Oxytetracycline Renal damage 1 1% 
   7 Aminoglycosides 
Neomycin Ototoxicity 5 5% 
Amikacin Hypotension 3 3% 
Framycetin Skin rashes 1 1% 
Gentamicin Incresaed Blood urea nitrogen  3 3% 
Tobramycin Ototoxicity 1 1% 
   8 Microlide antibiotics 
Azithromycin Abdominal pain 2 2% 
Erythromycin Seizures 3 3% 
   9 Quinolones 
Ofloxacin Dry mouth* Insomnia 1 1% 
Naliddixic acid Seizures 1 1% 
  10 Chloramphenicol Chloramphenicol Gray baby syndrome 4 4% 
 11 Nitroimidazole 
Metronidazole Insomnia 3 3% 
Tinidazole Metallic taste 1 1% 
12 Antitubercular drugs 
Pyrazinamide Hepatotoxicity 2 2% 
Streptomycin Pain at the site of injection 2 2% 
Cycloserine Convulsions 1 1% 
Ethambutol Optic neuritis 1 1% 
Isoniazid Hepatitis 2 2% 
Para amino 
salicylic acid 
Abdominal pain 2 2% 
Ethionamide Hair loss 1 1% 
Rifabutin Neutropenia 1 1% 
Kanamycin Nephrotoxicity 1 1% 
 13 Antileprotic drugs 
Clofazimine Brownish discolouration of skin 1 1% 
Dapsone Steven Johnson syndrome 1 1% 
14 Anti viral drugs 
Ganciclovir Bone marrow toxicity 1 1% 
Foscarnet Kidney damage 1 1% 
Zidovudine Anemia 1 1% 
Acyclovir Headache 1 1% 
15 Anti fungal drugs 
Voriconazole Impaired vision 1 1% 
Griseofulvin Skin rashes 1 1% 
Fluconazole Thrombocytopenia 1 1% 
16 
Miscellneous 
antibiotics 
Clindamycin Damage of nerves 3 3% 
Vancomycin Nephrotoxicity 2 2% 
Bacitracin Abdominal pain 1 1% 
Linezolid Vaginal candiasis 1 1% 
 
Table 2: Types of reactions observed (n=100): 
S. No. Types of Reactions No. of ADR % of ADR 
1.  Serious allergic skin reaction 3 3% 
2.  Metabolic acidosis 2 2% 
3.  Headache 2 2% 
4.  Diptheria 1 1% 
5.  Crystalluria 2 2% 
6.  Haemolytic anemia 1 1% 
7.  Hallucination 3 3% 
8.  Megaloblasticanemia 1 1% 
9.  Ulcers on tongue 1 1% 
10.  Ototoxicity 1 1% 
11.  Hypotension 1 1% 
12.  Angioedema 1 1% 
13.  Incresaed Blood urea nitrogen (BUN) 1 1% 
14.  Skin rashes 5 5% 
15.  Drug fever skin rashes 1 1% 
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16.  Swelling of lips 1 1% 
17.  Dizziness 3 3% 
18.  Anemia 3 3% 
19.  Nephrotoxicity 2 2% 
20.  Vestibular damage 1 1% 
21.  Rashes 1 1% 
22.  Hepatitis with cholestatic jaundice 1 1% 
23.  Damage of nerves 1 1% 
24.  General moniliaris 1 1% 
25.  Abdominal pain 5 5% 
26.  Diptheria 1 1% 
27.  Vaginal candiasis 1 1% 
28.  Rashes all over the body 1 1% 
29.  Erythema  peeling and burning of skin 1 1% 
30.  Impaired vision 1 1% 
31.  Cardiac arrhythmias 1 1% 
32.  Thrombocytopenia 1 1% 
33.  Black hairy tongue 1 1% 
34.  Bleeding 2 2% 
35.  Diarrhoea 3 3% 
36.  Hyperkalaemia 2 2% 
37.  Good pastures syndrome 1 1% 
38.  Asthma 1 1% 
39.  Migrane 1 1% 
40.  Diabetes insipidus 1 1% 
41.  JarischHerxheimer reaction 1 1% 
42.  Moderate rise in( ALT) 1 1% 
43.  Thrombophilibitis 1 1% 
44.  Muscle twitching 1 1% 
45.  Bone marrow toxicity 1 1% 
46.  Kidney damage 2 2% 
47.  Disulfuram like reaction 1 1% 
48.  Pulmonary edema 1 1% 
49.  Brownish black discolouration of skin 1 1% 
50.  Steven Johnson syndrome 1 1% 
51.  Inflamation of tongue 1 1% 
52.  Gray baby syndrome 1 1% 
53.  Insomnia 1 1% 
54.  Metallic taste 1 1% 
55.  Seizures 3 3% 
56.  Constipation 1 1% 
57.  Hepatotoxicity 1 1% 
58.  Pain at the site of injection 1 1% 
59.  Convulsions 1 1% 
60.  Optic neuritis 1 1% 
61.  Hepatitis 1 1% 
62.  Hair loss 1 1% 
63.  Neutropenia 1 1% 
64.  Ataxia vertigo nystagmus 1 1% 
65.  Dry mouth* insomnia 1 1% 
66.  Skin rashes 7 7% 
67.  Severe rashes 1 1% 
 
DISCUSSION 
Antimicrobials are the most frequently prescribed drugs 
among hospitalized patients especially in Department of 
General Medicine and DVL. Total of 100 ADRs were 
reported from 100 patients during the study period with 
female predominance (72%) over males. The average 
age of the patients in the study was found to be 55-80 
years. The majority of the ADRs occurred in the age 
group of 51-60 years. The cephalosporins were the most 
used antibiotic class in the inpatient settings, so that the 
reported ADRs were also more in these drug classes. A 
study  revealed the predominance of cephalosporins 
where as Aminoglycosides  were most accounted in a 
other study.
4,5
 while vancomycin and penicillins were 
most frequent in the other studies.
6-8
 Analysis of the type 
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of reported ADRs according to Rawlin and Thomson 
scale  revealed Type B predominance.
7
 This result is in 
line with the all the reported reactions were Type B 
reactions.
8-10 
Type A reactions are dose related and thus 
were preventable from their known pharmacology and 
therefore all of them were potentially avoidable.
11
 Eva 
states that Type B reactions comprise approximately 10–
15% of all ADRs and include hypersensitivity drug 
reactions.
12 The present study hints that pharmacists’ 
involvement may not only greatly increase the reporting 
rate but also quality of reporting. It is suggested that the 
most appropriate approach of medication control to 
minimize the incidence of ADR is screening the total 
medication of the individual patient by a hospital/clinical 
pharmacist and by taking history of allergy as well as 
past medication and medical history. Hospital/clinical 
pharmacists have also a greater role to play in the area of 
Pharmacovigilance to strengthen the national 
Pharmacovigilance program. Developing and 
maintaining electronic documentation of patients’ 
medical records may serve as a valuable tool to detect 
early signals of potential ADRs. In addition, creating 
intranet facilities within a hospital may help in easy 
access for healthcare professionals to updated patients’ 
medical records resulting in possible detection and 
prevention of ADRs. Also, the implementation of a 
computerized reporting system in hospital setup may 
hasten reporting of ADRs and is suggested. 
CONCLUSION 
A relatively high incidence of adverse drug events have 
been recorded which shows that not only Geriatric 
patients, but also adults are more susceptible to adverse 
drug effects. A number of drugs in combination were 
used, and ADEs often get multiplied. Careful therapeutic 
monitoring and dose individualization is necessary. This 
study strongly suggests that there is greater need for 
streamlining of hospital based ADR reporting and 
monitoring system to create awareness; and to promote 
the reporting of ADR among healthcare professionals of 
the country. Measures to improve detection and 
reporting of ADR by all health care professionals should 
be undertaken, to ensure patient's safety. 
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